BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29212930)

  • 21. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
    Piñon JD; Klasse PJ; Jassal SR; Welson S; Weber J; Brighty DW; Sattentau QJ
    J Virol; 2003 Sep; 77(18):9922-30. PubMed ID: 12941902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.
    Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I
    Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
    Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
    Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.
    Hoshino H
    Front Microbiol; 2012; 3():222. PubMed ID: 22737146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.
    Kiyokawa T; Yoshikura H; Hattori S; Seiki M; Yoshida M
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6202-6. PubMed ID: 6091139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
    Kusunoki H; Tanaka T; Ohshima C; Sakamoto T; Wakamatsu K; Hamaguchi I
    Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140708. PubMed ID: 34343702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
    Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
    Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
    Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
    Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.
    Shida H; Tochikura T; Sato T; Konno T; Hirayoshi K; Seki M; Ito Y; Hatanaka M; Hinuma Y; Sugimoto M
    EMBO J; 1987 Nov; 6(11):3379-84. PubMed ID: 2828027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
    Silverman LR; Phipps AJ; Montgomery A; Fernandez S; Tsukahara T; Ratner L; Lairmore MD
    Blood; 2005 Nov; 106(10):3602-8. PubMed ID: 16046523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
    Cook LB; Taylor GP
    Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers.
    Chen YM; Essex M
    AIDS Res Hum Retroviruses; 1991 May; 7(5):453-7. PubMed ID: 1873080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.